Study title: Publication in Rapport d'Expert sur la documentation clinique - Staudinger H - Update Dossier 24/03/1997 International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Management of Rhinitis - No Author - 1994 (Allergy 19:5-34)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: TRIAMCINOLONE | |||||
ATC code: R01AD11 | |||||
Document link: | |||||
Document date: | |||||
Study number: Nasacort AQ®, Expert Report on Clinical Documentation - Staudinger - 1997 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | - |